On optimal designs for clinical trials: an updated review (Q2301225): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
Import241208061232 (talk | contribs)
Normalize DOI.
 
(6 intermediate revisions by 4 users not shown)
Property / DOI
 
Property / DOI: 10.1007/s42519-019-0073-4 / rank
Normal rank
 
Property / describes a project that uses
 
Property / describes a project that uses: PERL / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: Controlled Optimal Design / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: PsN / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2994655586 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimum designs for two treatments with unequal variances in the presence of covariates / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5409931 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3445852 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive Designs to Maximize Power in Clinical Trials with Multiple Treatments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A theoretical analysis of the power of biased coin designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Compound optimal allocation for individual and collective ethics in binary clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5250225 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Compound optimal designs for percentile estimation in dose-response models with restricted design intervals / rank
 
Normal rank
Property / cites work
 
Property / cites work: Multi-treatment optimal response-adaptive designs for phase III clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Response-adaptive dose-finding under model uncertainty / rank
 
Normal rank
Property / cites work
 
Property / cites work: Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Bayesian design applied to logistic regression experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian experimental design: A review / rank
 
Normal rank
Property / cites work
 
Property / cites work: On multiple-objective optimal designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Locally Optimal Designs for Estimating Parameters / rank
 
Normal rank
Property / cites work
 
Property / cites work: Semiparametric Dose Finding Methods / rank
 
Normal rank
Property / cites work
 
Property / cites work: The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems / rank
 
Normal rank
Property / cites work
 
Property / cites work: Invited Discussion Paper Constrained Optimization of Experimental Design / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the Equivalence of Constrained and Compound Optimal Designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Designs for Dose-Finding Studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs for the emax, log-linear and exponential models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive designs for dose-finding based on efficacy-toxicity response / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Random Walk Rule for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Pharmacometrics / rank
 
Normal rank
Property / cites work
 
Property / cites work: Using the Canonical Design Space to Obtain c-optimal Designs for the Quadratic Logistic Model / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs and limiting optimal designs for a trinomial response / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Design for Nonlinear Response Models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal responses-adaptive designs based on efficiency, ethic, and cost / rank
 
Normal rank
Property / cites work
 
Property / cites work: Asymptotically Optimal Response‐Adaptive Designs for Allocating the Best Treatment: An Overview / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Optimal Designs for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Designs for Bivariate Logistic Regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: The Theory of Response‐Adaptive Randomization in Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials. / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4264744 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Minimax D‐Optimal Designs for the Logistic Model / rank
 
Normal rank
Property / cites work
 
Property / cites work: Maximum likelihood estimation in nonlinear mixed effects models / rank
 
Normal rank
Property / cites work
 
Property / cites work: D-optimal designs for logistic models with three and four parameters / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs for binary data under logistic regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs in Bioassay / rank
 
Normal rank
Property / cites work
 
Property / cites work: Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Finding Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint / rank
 
Normal rank
Property / cites work
 
Property / cites work: Penalized locally optimal experimental designs for nonlinear models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Penalized optimal designs for dose-finding / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs for contingent response models with application to toxicity-efficacy studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Adaptive Designs for Binary Response Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Handling covariates in the design of clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs for Dose Escalation Studies in Oncology / rank
 
Normal rank
Property / cites work
 
Property / cites work: Convergence properties of sequential Bayesian \(D\)-optimal designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design of clinical trials involving multiple hypothesis tests with a common control / rank
 
Normal rank
Property / cites work
 
Property / cites work: Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs for the logit and probit models for binary data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4365884 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4294316 / rank
 
Normal rank
Property / cites work
 
Property / cites work: On recent advances in optimal allocation designs in clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive clinical trial designs for phase I cancer studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Implementing Optimal Allocation in Sequential Binary Response Experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs for multiple treatments with unequal variances / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Semiparametric Sequential Algorithm for Estimation of Dose–Response Curve / rank
 
Normal rank
Property / cites work
 
Property / cites work: Recent advances in multiple‐objective design strategies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3473989 / rank
 
Normal rank
Property / cites work
 
Property / cites work: On Optimal Designs for Nonlinear Models: A General and Efficient Algorithm / rank
 
Normal rank
Property / cites work
 
Property / cites work: Support points of locally optimal designs for nonlinear models with two parameters / rank
 
Normal rank
Property / cites work
 
Property / cites work: An optimal allocation for response-adaptive designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4642533 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: Response-Adaptive Randomization for Survival Trials: The Parametric Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Implementing optimal allocation for sequential continuous responses with multiple treatments / rank
 
Normal rank
Property / DOI
 
Property / DOI: 10.1007/S42519-019-0073-4 / rank
 
Normal rank

Latest revision as of 21:52, 17 December 2024

scientific article
Language Label Description Also known as
English
On optimal designs for clinical trials: an updated review
scientific article

    Statements

    On optimal designs for clinical trials: an updated review (English)
    0 references
    0 references
    0 references
    0 references
    24 February 2020
    0 references
    estimation efficiency
    0 references
    dose-finding
    0 references
    multiple comparisons and modeling
    0 references
    optimal response-adaptive randomization
    0 references
    phase I/II studies
    0 references
    population PK/PD studies
    0 references
    power
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers